×

Glutamate agents in the treatment of mental disorders

  • US 10,052,318 B2
  • Filed: 05/15/2014
  • Issued: 08/21/2018
  • Est. Priority Date: 04/05/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a mental disorder in an individual in need thereof comprising administering to said individual a pharmaceutical composition comprising an effective amount of riluzole alone for treating said mental disorder, wherein said mental disorder is social anxiety disorder or panic disorder.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×